期刊文献+

胰岛素眼液及其促吸收剂对兔血糖的影响 被引量:1

Effects of insulin eyedrops and its enhancer on blood glucose of rabbits
暂未订购
导出
摘要 目的 本研究主要观察胰岛素眼液及其促吸收剂对兔血糖的影响。方法 不同浓度的胰岛素眼液及其促吸收剂滴入 30只 (30眼 )新西兰白兔眼内 ,然后 ,对其血糖及血浆胰岛素进行测量。结果 胰岛素眼液降低血糖的作用是剂量依赖性的 ,10 g· L- 1的胰岛素降血糖作用与 2 .5 g· L- 1 和 5 g· L- 1 的胰岛素给药组比较 ,具有显著性差异 (P<0 .0 5 ) ;促吸收剂 Tween80可加速胰岛素的吸收 ,尤其是 10 g· L- 1 的 Tween80 ,其促进胰岛素吸收的能力与 5 g· L- 1的 Tween80比较 ,具有显著性的差异 (P<0 .0 5 )。结论 胰岛素眼液及其促吸收剂对于糖尿病病人的临床治疗具有一定的意义。 Objective To investigate the effects of insulin eyedrops and its enhancer on the blood glucose in rabbits.Methods Different concentrations of insulin and its enhancer were instilled into the eyes of 30 New Zealand white rabbits, then the blood glucose and plasma insulin were measured at different time.Results The effects of insulin to lower the blood glucose were different depending on its concentration. The reducing effects between 10g·L -1 and 2.5g·L -1 or 5g·L -1 insulin were significantly different ( P <0.05).The enhancer Tween 80 could accelerate the absoption of insulin. Additionally, the effect of 10g·L -1 Tween 80 was significantly higher than that of 5g·L -1 Tween 80( P <0.05). Conclusion Insulin eyedrops and its enhancer can be used to treat diabetes in human by accelerating the absoption of insulin.
出处 《眼科新进展》 CAS 2000年第4期262-264,共3页 Recent Advances in Ophthalmology
关键词 血糖 糖尿病 胰岛素眼液 促吸收剂 insulin rabbit blood glucose
  • 相关文献

参考文献8

  • 11,Chiou GC,Chuang CY,Chang MS.Reduction of blood glucose concentration with insulin eye drops[J].Diabetes Care 1988;11(9)∶750-751.
  • 22,Chiou GC,Chuang CY.Improvement of systemic absorption of insulin through eyes with absorption enhancers[J].J Pharmacol Sci 1989;78(10)∶815-818.
  • 33,Chiou GC,Chuang CY,Chang MS.Systemic delivery of insulin through eyes to lower the glucose concentration[J].J Ocul Pharmacol 1989;5(1)∶81-91.
  • 44,Pillion DJ,Bartlett JD,Meezan E,et al.Systemic absorption of insulin delivered topically to the rat eye[J].Invest Ophthalmol Vis Sci 1991;32(12)∶3021-3027.
  • 55,Patton TF,Francoeur M.Ocular bioavailabity and systemic loss of topically applied ophthalmic drugs[J].Am J Ophthalmol 1978;85(2)∶225-229.
  • 66,Kaila T,Salminen L,Huuppanen R.Systemic absorption of topically applied ocular timolol[J].J Ocul Pharmacol 1985;1(1)∶79-83.
  • 77,Schwade ND,Albritton Ⅳ FD,Liu SXL.Comparison of systemic absorption of insulin via conjunctiva with punctum sealed and via normal eye with punctum opened[J].Drug Delivery 1993;1∶139-142.
  • 88,Lambert DW,Potter DE.Clinical Ophthalmic Pharmacology[M].Little Brown and Co.,Boston,MA.1987∶1-52.

同被引文献22

  • 1Lee Y-C,Simamora P ,Pinsuwan S, et al. Review on the systemic delivery of insulin via the ocular route. Int J Pharm,2002,233:1.
  • 2Nishihata T, Rytting J H. Absorption-promoting adjuvants :enhancing action on rectal absorption. Adv Drug Deliv Rev, 1997,28 : 205.
  • 3CN 1335182 A 13.
  • 4William A, Blair A,Thomas W, et al. Intranasal biovailability of insulin powder formulations effect of permeation enhancer-to protein ratio. J Pharm Sci,1991,80(8) :725.
  • 5Bj o k E, Edman P. Degradable starch microspheres as a nasal drug delivery system for insulin. Int J Pharm, 1988,47 : 233.
  • 6Takenaga M,Serizawa Y,Azeeiu Y, et al. Mieropartieae resins as a protential nasal drug delivery system for insulin. J Control Rel,1998,52(1-2):81.
  • 7Chiou G C Y,Chuang C Y. Improvement of systemic absorption of insulin through eyes with absorption enhancers. J Pharm Sci, 1989,78:815.
  • 8Simamora P,Lee Y-C,Yalkowsky SH. Ocular device for the controlled systemic delivery of insulin. J Pharm Sci, 1996,85 : 1128.
  • 9Lee Y-C,Simamora P, Yalkowsky S H. Effect of Brij-78 on systemic delivery of insulin from an oculardevice. J Pharm Sci, 1997,86(4):430.
  • 10Lee Y-C, Yalkowsky SH. Effect of formulation on the systemic absorption of insulin from enhancer-free ocular device. Int J Pharm,1999,85:199.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部